000 01406 a2200385 4500
005 20250518034351.0
264 0 _c20200922
008 202009s 0 0 eng d
022 _a1481-8043
024 7 _a10.1017/cem.2019.24
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHu, Tina
245 0 0 _aBuprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
_h[electronic resource]
260 _bCJEM
_c07 2019
300 _a492-498 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBuprenorphine, Naloxone Drug Combination
_xtherapeutic use
650 0 4 _aCanada
_xepidemiology
650 0 4 _aEmergency Service, Hospital
_xstatistics & numerical data
650 0 4 _aFemale
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNarcotic Antagonists
_xtherapeutic use
650 0 4 _aOpioid-Related Disorders
_xepidemiology
650 0 4 _aReferral and Consultation
_xstatistics & numerical data
650 0 4 _aRetrospective Studies
650 0 4 _aSubstance Abuse Treatment Centers
700 1 _aSnider-Adler, Melissa
700 1 _aNijmeh, Larry
700 1 _aPyle, Adam
773 0 _tCJEM
_gvol. 21
_gno. 4
_gp. 492-498
856 4 0 _uhttps://doi.org/10.1017/cem.2019.24
_zAvailable from publisher's website
999 _c29609561
_d29609561